Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Disease × Bleomycin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Hodgkin Disease 50 Lymphoma 45 Testicular Neoplasms 13 Teratoma 12 HIV Infections 12 Acquired Immunodeficiency Syndrome 11 Lymphoma, Large B-Cell, Diffuse 10 Lymphoma, Non-Hodgkin 9 Head and Neck Neoplasms 8 Endodermal Sinus Tumor 8 Testicular Germ Cell Tumor 7 Sarcoma, Kaposi 7 Neoplasms 7 Carcinoma, Embryonal 7 Seminoma 6 Lymphoma, Large-Cell, Immunoblastic 6 Lymphoma, Follicular 6 Ovarian Neoplasms 5 Ovarian Germ Cell Cancer 5 Recurrence 4 Neoplasms, Germ Cell and Embryonal 4 Neoplasm Metastasis 4 Carcinoma, Squamous Cell 4 Vulvar Neoplasms 3 Squamous Cell Carcinoma of Head and Neck 3 Teratoma, Testicular 2 Skin Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Drug-Related Side Effects and Adverse Reactions 2 Dendritic Cell Sarcoma, Interdigitating 2

Interventions

Magnetic Resonance Spectroscopy 6 Dexamethasone 6 Cyclophosphamide 6 Blood Specimen Collection 6 Prednisone 5 Positron Emission Tomography Computed Tomography 4 Mammography 4 Lenalidomide 4 Colonoscopy 4 pembrolizumab 3 Tomography, X-Ray Computed 3 Surveys and Questionnaires 3 Melphalan 3 Biopsy 3 2-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 3 weifuchun 2 obinutuzumab 2 fluciclovine F-18 2 daratumumab 2 carfilzomib 2 Preoperative Exercise 2 Positron-Emission Tomography 2 Methods 2 Magnetic Resonance Imaging 2 Injections 2 Gemcitabine 2 Exercise 2 Educational Status 2 Doxorubicin 2 Cytarabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01659099 2018-03-07

GAINED

The Lymphoma Academic Research Organisation

Phase 3 Terminated

Disease, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡